This week the FDA approved the oral GLP-1 analog, semaglutide (Rybelus) for the treatment of type 2 diabetes. This is the first oral medication in the class that includes liraglutide, exenatide and dulaglutide. The secret of making this work orally is a medium chain fatty acid, and our intern Nour …

Final results from a phase 3 study preceded FDA approval of oral semaglutide.

A secondary analysis of the LEADER trial to investigate the safety of liraglutide in patients with type 2 diabetes. 

Both patients and HCPs should be aware of early signs of kidney issues.

Association strongest in younger and middle-aged groups and for diabetes-related deaths

Individuals with poor and intermediate versus good health more likely to continue insulin use

In the first month after Katrina and Rita, all-cause mortality spiked 40 percent among seniors with diabetes

However, increasing lean body mass does not appear to have a protective effect

Findings seen among patients with heart failure, reduced ejection fraction, irrespective of diabetes

Quite often we see patients that we feel should lose some weight, but when we do the labs and physical checkup everything else seems perfect. That makes it hard to really talk to the patient about losing weight, but now Nadeen Ayad, BCPS, PharmD Candidate, University of Colorado, has researched …